You have not yet added any article to your bookmarks!
Join 10k+ people to get notified about new posts, news and tips.
Do not worry we don't spam!
Post by : Badri Ariffin
The Department of Health – Abu Dhabi (DoH) has established a strategic alliance with the global biopharmaceutical firm Boehringer Ingelheim to boost precision medicine research by utilizing Abu Dhabi's sophisticated genomics resources.
This partnership was formalized at the BIO International Convention 2026 in San Diego, focusing on deepening the scientific understanding of genetic influences on disease progression and treatment responses.
Research to address various medical conditions
The collaboration will undertake extensive studies spanning major health issues as well as rare diseases. This includes conditions like cardiovascular disease, diabetes, cancer, and neurological disorders.
Such research aims to enhance the comprehension of disease mechanisms and advance personalized treatment strategies for patients.
Innovative genomics ecosystem of Abu Dhabi
Leveraging Abu Dhabi's robust genomics and biobanking infrastructure, the collaboration is set to generate crucial insights that can lead to more tailored healthcare solutions.
By integrating advanced genomic studies with healthcare data, the initiative seeks to foster the evolution of precision medicine and elevate patient care standards.
Official commitment to personalized healthcare
Dr. Asma Al Mannaei, Executive Director of the Health Life Sciences Sector at DoH, commented that the partnership underscores the emirate's dedication to enhancing population health research while reinforcing personalized medicine.
She emphasized that the collaboration illustrates Abu Dhabi's ongoing commitment to leveraging scientific advancements to enhance healthcare outcomes.
Boehringer Ingelheim targeting unmet medical needs
Boehringer Ingelheim highlighted that the collaboration is aimed at addressing unmet medical requirements by amalgamating cutting-edge research, data, and innovation.
The company noted that this partnership is geared towards optimizing patient outcomes while advancing the region's healthcare future.
Union of European Clubs Challenge UEFA and EFC Over EU Competition Rules
UEC files an EU competition complaint against UEFA and EFC, challenging club representation, governa
Mohammed Shami Retires From Test Cricket, Eyes White-Ball Career
Mohammed Shami retires from Test cricket after 13 years, with 229 wickets. He will continue playing
Singapore Warns Users About Privacy and Security Risks of AI Agents
Singapore warns users about AI agent security risks, data privacy, online scams and unauthorised acc
Chris Lynn Completes One-Month Ban After Positive Cocaine Test
Australian cricketer Chris Lynn completes a one-month ban after a positive cocaine test during the T
Djokovic Eyes Strong Season Finish as Health Improves Ahead of Paris Masters
Novak Djokovic reports improved health and performance as he targets a strong Paris Masters finish a
SpaceX in Talks to Buy Boost Mobile or Use Its Network
SpaceX reportedly explores a Boost Mobile deal with EchoStar to expand Starlink Mobile and challenge